Neimeth International Pharmaceuticals Plc has appointed Pharm. Matthew Obi Azoji as its new Managing Director (MD)/Chief Executive Officer (CEO). The company disclosed this in a notice sent to the Nigerian Stock Exchange (NSE) today.
Pharm. Matthew Obi Azoji’s profile
Pharm. Azoji graduated from the Obafemi Awolowo University, Ile-Ife, Osun State, where he obtained his B. Pharm (First Class Honours). He went on to obtain an MBA (Marketing) from the Enugu State University of Science and Technology, Enugu, and an Advanced Management Programme (AMP) from the Lagos Business School; Pan Atlantic University, Lagos.
He obtained certificates in Pharmaceutical Policy & Pharmacoeconomics from Utrecht University in the Netherlands (a WHO Collaborating centre), and went on to get his M.Sc. in Public health from the University of London, International Programmes. He obtained his M.Phil (Pharmacy Administration) from Obafemi Awolowo University, lle-Ife. Presently, a PhD (Clinical Pharmacy & Pharmacy Practice) from the University of Jos, Jos Plateau State is in view.
Pharm. Azoji is Fellow, Pharmaceutical Society of Nigeria (FPSN) and Fellow, West African Postgraduate College of Pharmacists (FPCPHARM). He is a Member, International Pharmaceutical Federation (FIP), Founding Member, Health Systems Action Network (HSAN), Member, Nigerian Institute of Management (MNIM), Member, National Institute of Marketing of Nigeria and Member, Nigerian Association of Industrial Pharmacists.
He began his professional career as a Hospital Pharmacist at General Hospital Saminaka, Kaduna State in 1986 serving our country during his National Youth Service Corps (NYSC) year. Prior to this, he had a one year internship programme at Obafemi Awolowo University, lle-Ife as a Demonstrator/Internee. He had a brief stint with Astra-Arewa Pharmaceuticals Ltd, Kaduna as a Medical Representative based in Kano. He joined May & Baker Nigeria Plc in 1988, and served there till 2004, during which time he rose from the position of Medical Representative to occupy the positions of Asst. Manager – Ethical Product Sales, Area Manager – North, Sales & Market Development Manager, Regional Sales Manager – Lagos/South West, Business Manager – Healthcare, Business Manager – Consumer and Head, Corporate Planning & Development. He was the pioneer MD/CEO, CHAN Medi-Pharm Ltd/Gte, Jos, Plateau State from 2004 till Sept. 2018.
Pharm. Azoji served on the boards and management of Ecumenical Pharmaceutical Network (EPN) and Africa Christian Health Associations Platform (ACHAP) both based in Nairobi, Kenya.
Neimeth International Pharmaceuticals Plc was incorporated on 30th August 1957 as a limited liability company. It commenced operations in 1958. On May 14th, 1997, Pfizer NY divested from the company through a management buyout. The company then underwent a name change to Neimeth Plc.
Neimeth is currently trading at N0.70 in today’s session on the Nigerian Stock Exchange (NSE).
Peter Obaseki resigns as Director from the Board of FCMB Plc
Mr Peter Obaseki has resigned as a Director on the Board of FCMB Group Plc.
The Board of FCMB Group Plc has announced the resignation of Mr Peter Obaseki as an Independent Non-Executive Director of the company.
The notification is part of the decisions reached at the company’s Board meeting held today, 26th of February, 2021.
According to the disclosure signed by the company’s secretary, Mrs. Olufunmilayo Adedibu, the resignation of Mr Obaseki from the Board of the company will become effective from 1st of March, 2021.
In lieu of this, the Board wished the outgoing Director well in his future endeavours and accepted his resignation in good faith. Other decisions reached at the Board of Directors’ meeting include;
- The Board considered and approved the appointment of an Independent Non-Executive Director, subject to CBN approval.
- It also considered and approved the Group’s audited financial statements for the year ended December 31, 2020 as well as payment of Dividend, subject to the approval of the CBN.
What you should know about Obaseki:
- Mr. Peter Obaseki has over 27 years working experience across financial consulting and banking. Prior to joining FCMB Plc in 1997, Mr Obaseki gained valuable experience in firms like KPMG, Ani, Ogunde & Co and some banks.
- He is a fellow of the Chartered Institute of Bankers and was appointed an executive director of FCMB in September 2008.
- Apart from being an Independent Non-Executive Director, Mr. Peter Obaseki also doubled as the Chief Operating Officer of FCMB.
FCMB closed trading with a share price of N3.03 as at the 26th of February 2021.
AXA Mansard emerges Best Health Insurance Product Winner 2021
The winning product was the AXA Platinum Plus Cover which has been specially designed to provide a world-class health cover for the insurer’s customers.
Health Management Organization, AXA Mansard Health Limited, recently announced that it has emerged as the winner of the best health insurance product of the year in the Insurance Product & Process section of the just concluded 11th Annual Global Banking and Finance Awards 2021.
The winning product was the AXA Platinum Plus Cover which has been specially designed to provide a world-class health cover for the insurer’s customers. With access to roam over 1,700 hospitals locally, care in India, UAE and South African hospitals and limited in-patient cover in the UK, France, and Germany for up to $1000 in healthcare benefits.
The product provides enrolees with benefits such as twenty-four-hour dedicated Telemedicine service, home vaccination service, free home delivery of special medications, partnership with healthy eating restaurants, and smarter budget-friendly discounts on healthy meals.
Speaking on the award, Chief Executive Officer, AXA Mansard Health Limited, Tope Adeniyi, said “We thank our highly esteemed customers for this prestigious award, as they are the reason, we passionately drive to improve our product offerings and execute innovative initiatives. This award is recognition of our unflinching commitment to our customers and an affirmation of our current position as the leading health insurance company in the country.”
AXA Mansard Health has a twenty-four-hour call centre, a team of highly trained and dedicated professionals, service portals at all AXA Mansard Welcome Centres nationwide and has deployed state-of-the-art technology to attain operational excellence while contributing to prompt service delivery and overcoming of challenges being encountered in the Nigerian health insurance industry.
Whilst thanking the organizers, Adeniyi noted that “the company is counting on the continued support of our stakeholders to continuously provide superior customer experience and to develop more innovative and value-adding products. We will continue to innovate, create new products, improve our product offering and refine our service delivery to ensure we continuously meet the changing needs of our customers”.
AXA Mansard Health Limited is the Health Maintenance Organization (HMO) arm of the AXA Mansard group of companies. The HMO is geared to promote her members’ wellbeing.
The HMO serves all clients across the country virtually and has established functional offices in Lagos (the head office), Abuja, Port-Harcourt, Enugu, with ongoing plans to open offices in other locations.
Global Banking & Finance Review is a leading Online and Print Magazine, which has evolved from the growing need to have a more balanced view, for informative and independent news within the financial community.
Since its inception in 2011, The Awards reflect the innovation, achievement, strategy, progressive and inspirational changes taking place within the Global Financial community. According to the magazine’s publishers the awards were created to recognize companies prominent in their areas of expertise and excellent in financial service delivery.
Nairametrics | Company Earnings
- 2020 FY: WEMA Bank posts N5.06 billion profit after tax as earnings per share prints at N13.1.
Wema Bank Plc released […]
- 2020 FY: Zenith Bank post N230.6 billion profit after tax
Zenith Bank Plc released its […]
- Mutual Benefits Assurance Plc boosts post tax profits by 25.9%
Mutual Benefits Assurance Plc released […]
- 2020 FY Results: Prestige Assurance Plc reports a 50.44% increase in profit.
Prestige Assurance Plc released its […]
- John Holt falls deeper into losses
John Holt Plc released its […]